نتایج جستجو برای: hcv genotype

تعداد نتایج: 109082  

2014
Rénovat Ntagirabiri Jean Dominique Poveda Annie Mumana Hermelance Ndayishimiye

INTRODUCTION Hepatitis C virus (HCV) infection is a major public health issue. HCV genotype identification is clinically important to tailor the dosage and duration of treatment. Indeed, distinct therapeutic approaches are required for each genotype. Up to now, there is no study assessing HCV genotypes and subtypes in Burundi. The aim of the study was to determine HCV genotypes and subtypes in ...

2017
Jürgen K Rockstroh Chloe Orkin Rolando M Viani David Wyles Anne F Luetkemeyer Adriano Lazzarin Ruth Soto-Malave Mark R Nelson Sanjay R Bhagani Hartwig H F Klinker Giuliano Rizzardini Pierre-Marie Girard Cristina Tural Nancy S Shulman Niloufar Mobashery Yiran B Hu Linda M Fredrick Tami Pilot-Matias Roger Trinh Edward Gane

BACKGROUND Ombitasvir, paritaprevir with ritonavir, and dasabuvir (OBV/PTV/r ± DSV) ±ribavirin (RBV) are approved to treat hepatitis C virus (HCV) genotype 1 and 4 infection. Here, we investigate the safety and efficacy of OBV/PTV/r + DSV ±RBV for HCV genotype 1, and OBV/PTV/r + RBV for HCV genotype 4, in human immunodeficiency virus (HIV)-1 coinfected patients with or without compensated cirrh...

Journal: :Journal of gastrointestinal and liver diseases : JGLD 2009
Mircea Grigorescu

AIM To investigate the HCV genotype distribution in Romania in the first national study, to establish the correlations with epidemiological, biochemical, virological and histological features and to compare our results with those from neighboring countries. PATIENTS AND METHODS Two distinct groups of patients and two methods were used: 153 patients in the frame of ACHIEVE study with genotypin...

Journal: :Clinics and research in hepatology and gastroenterology 2015
Hao Zheng Man Li Bing Chi Xiao-xue Wu Jia Wang Dian-Wu Liu

BACKGROUND AND OBJECTIVE The IL-28B rs12979860 CC and rs8099917 TT genotypes were proved to be predictor for pegylated-interferon (PEG-IFN)/ribavirin (RBV)-treated hepatitis C virus (HCV) patients. However, there were no identical conclusions on rs12980275 polymorphism. Our aim is to perform a meta-analysis in order to determine the association between rs12980275 polymorphism of IL28B and the s...

M Mahmoudian Shooshtari , Z Sharifi ,

Abstract: Genotyping of the hepatitis C virus (HCV) is important for designing therapeutic strategies and regional specific diagnostic assays. The aim of this study was to identify the HCV genotypes in HCV infected blood donors. This is the first report on HCV genotypes in blood donors in Iran. In this cross-sectional study, 103 blood donors with hepatitis C were investigated for HCV genotype...

Journal: :Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 2006
L K Silva M B S Silva I F Rodart G B Lopes F Q Costa M E Melo E Gusmão M G Reis

Hepatitis C virus (HCV) infection has been identified as the major cause of chronic liver disease among patients on chronic hemodialysis (HD), despite the important reduction in risks obtained by testing candidate blood donors for anti-HCV antibodies and the use of recombinant erythropoietin to treat anemia. A cross-sectional study was performed to estimate the prevalence of HCV infection and g...

Journal: :Liver international : official journal of the International Association for the Study of the Liver 2014
Gamal Esmat Mohamed El Kassas Mohamed Hassany Mohamed Gamil Maissa El Raziky

Hepatitis C virus (HCV) remains one of the leading causes of morbidity and mortality worldwide. Combined therapy with pegylated interferon (PEG-IFN) and ribavirin is the current standard of care treatment for HCV genotype 4. Two types of PEG-IFN are commercially available. The limited number of trials that were conducted for HCV genotype 4 and the few head to head comparisons make it impossible...

2017
Ayman Ahmed Sakr Jasmine M. Hanifi Ming Valerie Lin

Mixed hepatitis C virus (HCV) genotype infection is emerging with improved methods of detection. It is commonly seen in hemodialysis patients and intravenous drug users due to repeated HCV exposure and absence of protective immunity, and can contribute to treatment failure. Direct-acting antiviral regimens have been extensively studied in patients with different individual HCV genotypes; howeve...

2011
Elena LuminiŃa Enache Liviu S. Enache

Hepatitis C virus (HCV) is a major cause of chronic liver disease, the prevalence of the infection being currently estimated at approximately 170 milion persons worldwide. HCV isolates have been classified into six main genotypes. Quick and accurate genotyping of HCV is becoming increasingly important for clinical management of chronic infection and as an epidemiological marker. Genotyping meth...

2014
Malgorzata Tyczyno Waldemar Halota Wojciech Nowak Małgorzata Pawlowska

BACKGROUND According to many studies, one of the social groups with high rate of HCV infections are prisoners. OBJECTIVES The aim of the study was to determine and compare the genotypes distribution among prisoners and patients of hospital. PATIENTS AND METHODS HCV genotypes among prisoners (281 inmates) and patients of hospital (1415 patients) were determined in years 2002-2012. HCV genoty...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید